BiDil for heart failure in black patients.
Jonathan D
JD
Kahn
D044383:Black People; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D017277:Drug Approval; D004338:Drug Combinations; D006333:Heart Failure / Q000188:drug therapy* / Q000208:ethnology*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D007548:Isosorbide Dinitrate / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D001741:Black or African American
D002317:Cardiovascular Agents; D004338:Drug Combinations; C431665:isosorbide-hydralazine combination; D006830:Hydralazine; D007548:Isosorbide Dinitrate